Buy Apretude Injectable Suspension Online

Apretude Injectable Suspension is a long-acting cabotegravir injection used for HIV-1 pre-exposure prophylaxis, or PrEP, to help reduce the risk of getting HIV from sex. It can be bought online through BorderFreeHealth, with the 600 mg/3 mL strength matched to the injection plan set by your healthcare clinic. This clinic-administered medicine is supplied as cabotegravir extended-release injectable suspension, also expressed as 200 mg/mL.

Apretude is not a daily tablet and is not used to treat established HIV infection. It is given as a gluteal intramuscular injection by trained healthcare staff, with ongoing HIV testing and appointment timing built into safe use. If you are coordinating Apretude US delivery from Canada, plan around clinic storage, preparation, and administration needs rather than the injection date alone.

Because long-acting PrEP depends on consistent dosing and monitoring, your order should reflect the exact strength, quantity, and timing your clinic expects. The sections below focus on Apretude price factors, how ordering works, what the injection is used for, practical handling, side effects, interactions, and related HIV prevention choices.

Apretude Price and 600 mg Injection Details

The Apretude price you see during ordering is tied to the cabotegravir injectable suspension strength, quantity, and current store pricing. The key product identifier is Apretude 600 mg injection in a 3 mL single-dose vial, equivalent to Apretude 200 mg/mL. Match that strength to the clinic plan before checkout, since injectable PrEP is not interchangeable with oral PrEP tablets.

Apretude cost can involve more than the medicine itself. A full cash-pay estimate may include the injection product, clinic administration, HIV testing, STI screening, and follow-up visits. Those clinic and laboratory charges are usually separate, so it helps to ask your healthcare site what is included in its visit fee.

People considering Apretude without insurance often compare long-acting injectable PrEP with daily oral PrEP, public health programs, and local clinic services. Cash-pay ordering can be useful when other coverage routes are limited, but it should still support safe testing and follow-up. Keep one record of prior injection dates, upcoming clinic appointments, and recent HIV test results so the next step is easier to coordinate.

Quick tip: Confirm the 600 mg/3 mL strength and quantity with your clinic before placing an order.

How to Order Apretude Online

To order Apretude online, choose the cabotegravir injectable suspension strength that matches the clinic-administered schedule. The order process may request information needed to confirm the medicine, quantity, and handling requirements. We may also review order details when pharmacy checks are needed before the medicine is released.

BorderFreeHealth offers cash-pay access to regulated medicines supplied through licensed pharmacy channels. For Apretude, practical planning matters because the vial must be available in time for clinic preparation and administration. If an injection appointment is already booked, allow enough time for the clinic to receive and store the medicine according to labeling.

Apretude Ships from Canada to US through the site’s order process, and prompt, express shipping may be available. Shipping speed should not replace clinical scheduling advice, especially when missed or late injections can affect PrEP planning. Contact the clinic early if travel, illness, or appointment changes may interfere with the injection window.

What This HIV PrEP Injection Is Used For

Apretude is used for HIV-1 pre-exposure prophylaxis to reduce the risk of acquiring HIV from sex in adults and adolescents who weigh at least 35 kg and are at risk. PrEP means taking medicine before possible exposure to help prevent infection. This medicine is for people who are HIV-negative before starting and remain HIV-negative during ongoing injections.

Apretude contains cabotegravir, an HIV-1 integrase strand transfer inhibitor. Integrase is an enzyme HIV uses to insert its genetic material into human cells. By blocking this step, cabotegravir helps prevent HIV infection from becoming established when the medicine is used on schedule.

Long-acting injectable PrEP may appeal to people who prefer not to take a daily pill or who have difficulty maintaining daily tablet routines. It still requires clinic visits, repeat HIV testing, and a plan for missed appointments. For a plain-language explanation of prevention approaches, see What Is PrEP Medication.

Form, Strength, and Injection Schedule

Apretude Injectable Suspension is supplied as an extended-release suspension for intramuscular injection into the gluteal muscle. The labeled strength is cabotegravir 600 mg/3 mL, equal to 200 mg/mL. The suspension does not require dilution or reconstitution, but clinic staff must prepare and administer it according to official directions.

The usual Apretude injection schedule begins with two initiation injections about one month apart. Maintenance injections are then commonly given about every two months. Some people may use oral cabotegravir before injections to assess tolerability, but that choice depends on individualized clinical planning.

Dose timing matters because cabotegravir levels need to remain high enough for PrEP protection. If an appointment is delayed, ask the clinic about label-directed next steps rather than stretching the schedule on your own. A clinician may discuss oral bridging or another prevention method when ongoing exposure risk continues.

Why it matters: The right vial strength and appointment timing work together for long-acting PrEP.

Testing and Monitoring During Use

HIV testing is central to safe Apretude cabotegravir use. Clinics typically confirm HIV-negative status before starting and repeat testing before ongoing injections. This is important because using cabotegravir during undiagnosed HIV infection can contribute to drug-resistant virus.

A healthcare professional will usually ask about recent possible exposures, symptoms that could suggest acute HIV infection, and other medicines or supplements. Fever, rash, sore throat, swollen glands, or unexplained fatigue can overlap with early HIV and many other illnesses. Testing decisions should account for symptom timing and recent risk.

PrEP visits may also include STI screening, pregnancy-related discussion when relevant, and review of liver history or other clinical concerns. The HIV collection can help you browse related condition topics while you keep medical decisions with your care team.

Storage, Handling, and Clinic Logistics

Storage instructions should follow the carton and official Apretude labeling. Injectable suspensions may be affected by temperature extremes, light, and freezing. In many cases, the clinic or pharmacy handles storage until the injection visit, but the handoff should be planned if the vial is sent to you first.

Before administration, clinic staff may allow the vial to reach room temperature as directed, inspect the suspension, and prepare it for injection. Because the dose is injected into the buttock muscle, the clinic may ask about bleeding disorders, anticoagulant use, or previous injection-site problems. Tell the clinic if you have had severe reactions to injectable medicines.

Travel requires early planning. If you expect to be away during an injection window, contact the clinic before the date is close. Long-acting injectable PrEP should not rely on last-minute shipment changes or rushed appointment scheduling.

Side Effects, Warnings, and Interactions

The most common Apretude side effects are injection-site reactions. These can include pain, tenderness, swelling, firmness, warmth, redness, itching, bruising, or a lump where the injection was given. Many reactions improve with time, but severe, worsening, or persistent symptoms should be reported to a healthcare professional.

Other reported effects may include headache, fever, tiredness, muscle aches, joint pain, nausea, dizziness, sleep changes, and rash. Mood changes, including depression or anxiety symptoms, have also been reported with medicines in this class. Mention new or worsening mood symptoms promptly, especially if they affect sleep, safety, relationships, or daily function.

Serious allergic or hypersensitivity reactions can occur. Seek urgent help for trouble breathing, swelling of the face or throat, severe rash, blistering, or a reaction that feels rapidly worse. Liver problems are another important concern; warning signs can include yellowing skin or eyes, dark urine, pale stools, severe nausea, or upper abdominal pain.

Apretude has a prolonged pharmacokinetic tail, meaning cabotegravir levels decline slowly after the last injection. If injections stop and HIV exposure risk continues, a clinician may recommend another prevention method during that tail period. This is one reason missed or stopped injections should be planned with clinical guidance.

Some medicines can lower cabotegravir levels and may reduce PrEP protection. Important examples include rifampin and rifapentine, certain seizure medicines such as carbamazepine, phenytoin, phenobarbital, and oxcarbazepine, and the herbal supplement St. John’s wort. Share all prescription medicines, over-the-counter products, and supplements before starting or continuing the injection schedule.

Apretude is not appropriate for people with known HIV infection or a history of serious hypersensitivity to cabotegravir. Extra caution may be needed with liver disease, pregnancy, breastfeeding, or symptoms that could represent acute HIV infection. Clear terminology can help conversations about prevention and treatment; How Is HIV Transmitted explains common exposure routes in patient-friendly language.

How Apretude Compares With Other HIV Prevention Options

Apretude injection is one long-acting HIV prevention option. Daily oral PrEP tablets may be preferred when someone wants a medicine that can be started, paused, or changed more quickly under clinical guidance. Event-driven oral PrEP is used in some settings for certain people, but it is not suitable for everyone and is not the standard approach everywhere.

Post-exposure prophylaxis, or PEP, is different from PrEP. PEP is used after a possible exposure and must be started quickly with professional guidance. If you are sorting prevention and treatment terms, Tenvir-EM and other HIV medication options discusses treatment and prevention distinctions.

HIV prevention also involves knowing how transmission risk works. Questions about undetectable viral load, sexual transmission, and prevention layers often come up when people choose between injectable and oral PrEP. The article Can You Get HIV From Someone Undetectable provides additional background for conversations with a clinician.

Related Products and Categories

Some customers browse related antiviral medicines to understand how HIV prevention and treatment products differ. The Antivirals category brings together products used across viral conditions, including HIV-related therapies. Category browsing can support product identification, but it should not replace individualized clinical selection.

If a clinician is considering oral PrEP instead of long-acting cabotegravir injectable suspension, Descovy may be useful for recognizing a commonly discussed oral option. Tavin-EM is another HIV-related product that may appear in prevention or treatment conversations depending on the local care plan.

HIV treatment products are different from PrEP products. For example, Biktarvy is used in HIV treatment contexts and should not be treated as interchangeable with Apretude for prevention. If vaccine questions are part of your prevention planning, Is There a Vaccine to Prevent HIV explains the current prevention landscape in plain language.

Practical Access Notes for Cash-Pay Planning

Apretude cost without insurance can be a major planning factor because the product, injections, and laboratory monitoring may be billed separately. Ask your clinic which charges are included in the visit and which are separate. That makes it easier to understand the full out-of-pocket amount before scheduling several months of care.

Manufacturer programs, public health clinics, community organizations, and local prevention services may also affect the most practical route. BorderFreeHealth can support cash-pay ordering for U.S. customers using Canada-to-U.S. service wording when it fits the order. Final planning should still account for clinic appointment dates, testing, storage, and administration workflow.

Keep documentation organized in one place. Useful items include injection dates, next appointment windows, recent HIV test dates, clinic contact information, current medicines, and any history of injection reactions. Good organization can prevent delays when an injection window is approaching.

Authoritative Sources

Official labeling is the best source for fixed Apretude information, including indication, strength, administration, contraindications, missed-dose instructions, warnings, and drug interactions. Use authoritative sources together with clinic instructions, because labeling gives product requirements while healthcare professionals apply them to your testing history, exposure timing, other medicines, and appointment logistics.

• FDA Apretude prescribing information describes labeled use, dosing, warnings, administration, and interactions.

This content is for informational purposes only and is not a substitute for professional medical advice.